Conferences organized by the department
|S.No||CME||Topic||Organized by||Speaker details||Date|
|1||Continuing Medical Education (CME)||Recent Advances in Cancer Biology, Organised by Department of Biotechnology||Central Library auditorium, SRIHER.
||1.Dr Krishna C Vallabhaneni,Biotechnology Alumni-SRU, Currently Faculty of Radiation Oncology, University of Mississippi Medical Centre, Mississippi, USA.
2.Dr Hannah Rachel Vasanthi.A, Associate Professor, Department of Biotechnology, Pondicherry University,
3. Dr Thanka.J, Professor & Head, Department of Pathology, SRIHER, Chennai.
|2||Continuing Medical Education (CME)||Unspoken communications in the oral cavity: how a pathogen become the dominant species||Department of Biotechnology||Dr. Indranil Biswas, Dr. Indranil Biswas, Professor, Department of Microbiology, University of Kansas Medical Centre, USA||10/07/2014|
|3||CME||Herpes viruses: Guests that come home but never leave||Central Research facility and Faculty of Biomedical Sciences||Dr. Ravi Mahalingam, Research Professor, Department of Neurology, University of Colorado School of Medicine, USA||13/03/2014|
|4||Career guidence programs||“SAS and Clinical Data Analytics”||Department of Biotechnology||Epoch Research Institute India Pvt. Ltd.||03/04/2013|
|5||CME||Varicella viruses: guests that come and stay forever||Central Research Facility, Department of Biotechnology, Department of Biomedical Sciences, SRIHER||JSpeaker: Ravi Mahalingam Ph.D, Research Professor, Department of Neurology, University of Colorado School of Medicine, USA||12/03/2013|
|6||CME||Microenvironment Decides Stem Cell Fate in Tissue Engineering||Department of Biotechnology, SRIHER||Speaker: Rajalakshmanan Eswaramoorthy, PhD, Post Doctoral Researcher, Department of Biomedical Engineering, University of California, Davis, California, USA||20/02/2013|
|7||CME||Novel therapeutic targets for Atherosclerosis||Department of Biotechnology, SRIHER||Dr. Dheenadayalan Bakthavatsalam,||03/10/2012|
|8||CME||Hepatocellular Carcinoma: Focus on Generating Relevant Mouse Model||Department of Biotechnology, SRIHER||Dr. Saradha Mokkapati, Department of Genetics, MD Anderson Cancer Centre, Texas University, Houston, USA||03/10/2012|
|9||CME||Mesenchymal stem cells in vascular repair”||Department of Biotechnology, SRIHER||Dr. Krishna Chaitanya, Department of nephrology, Hannover Medical School, Germany||15/09/2012|
|10||CME||Biosimilars: From bench to bedside||Department of Biotechnology, SRIHER||Dr. Jonnala Ujwal, Scientist, In Vitro Biology, Vimta Labs Ltd, Hyderabad||15/09/2012|
|11||CME||Cancer Immunology||Department of Biotechnology, SRIHER||D. Sriram, Senior Scientist, Oncology (Biologics), Merck, California||03/10/2012|
|12||CME||Gene silencing: Rounding up usual suspects||Department of Biotechnology, SRIHER||Dr. V. V. Sridhar, Assistant Professor, Department of Biological Sciences, University of New Orleans, USA||22/06/2012|
|13||CME||Cancer stem cells, Casein Kinase-2 and a Telomerase inhibitor Drug||Department of Biotechnology, SRIHER||Dr. Immanual Joseph, Scientist I, Preclinical discovery research, Geron Corporation, Menlo Park, CA||08/06/2012|